These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 18464343
1. Schedules of controlled substances; exempt anabolic steroid products. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Mar 17; 73(52):14178-9. PubMed ID: 18464343 [Abstract] [Full Text] [Related]
2. Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2009 Dec 04; 74(232):63603-10. PubMed ID: 20169675 [Abstract] [Full Text] [Related]
3. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule. Drug Enforcement Administration, Department of Justice. Fed Regist; 2005 Apr 04; 70(63):16935-7. PubMed ID: 15806735 [Abstract] [Full Text] [Related]
5. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Jul 25; 73(144):43355-7. PubMed ID: 18949877 [Abstract] [Full Text] [Related]
11. Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2012 Jul 30; 77(146):44456-62. PubMed ID: 22844688 [Abstract] [Full Text] [Related]
13. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Jul 10; 73(133):39611-4. PubMed ID: 18850676 [Abstract] [Full Text] [Related]